| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT05326932 Large Artery Occlusion Treated in Extended Time With Mechanical Thrombectomy Trial |
Enrollment reduced: 382 -> 336 participants |
| 2026-06-12 | NCT05326932 Large Artery Occlusion Treated in Extended Time With Mechanical Thrombectomy Trial |
Sponsor changed: The George Institute for Global Health, China -> Fudan University |
| 2026-06-10 | NCT07505602 Air Purifier Use and Respiratory Health in COPD Patients |
Recruitment opened |
| 2026-05-27 | NCT07557849 Multicentric Database for KRAS Mutant Pancreatic Cancer |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-10 | NCT07638774 The Efficacy of Compression/Ice Gloves/Socks in Patients With UTD1-induced Neuropathy. | Recruiting | |
| 2026-06-10 | NCT07638852 Study of Radiotherapy Combined With Platinum, Adebrelimab and Bevazumab in the Treatment… | Phase 2 | Recruiting |
| 2026-06-05 | NCT07628504 Sac-TMT Sequential Capecitabine Versus Capecitabine in Early-Stage High-Risk… | Phase 3 | Not Yet Recruiting |
| 2026-06-04 | NCT07626177 Association Between Screening Behaviors and Lung Cancer Spectrum | Recruiting | |
| 2026-06-03 | NCT07623577 Sac-TMT Combined With Bevacizumab in TNBC With Brain Metastases | Phase 2 | Recruiting |
| 2026-06-02 | NCT07619911 SHR-1701 for Induction and Consolidation Therapy in Unresectable Stage III Non-Small Cell… | Phase 2 | Not Yet Recruiting |
| 2026-06-01 | NCT07617181 Probiotics Supplementation for Neurodevelopment in Preterm Infants | Not Yet Recruiting | |
| 2026-05-29 | NCT07615751 Pyrotinib and Trastuzumab Combined With Dalpiciclib Versus Combined With Docetaxel in… | Phase 3 | Recruiting |
| 2026-05-28 | NCT07610733 Impact of Formulation Change on Ovarian Suppression in Young Breast Cancer Patients. | Phase 2 | Not Yet Recruiting |
| 2026-05-28 | NCT07612436 AI-empowered Nudge to Improve Colonoscopy Uptake (AINC) | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07445022 | RWS of Tunlametinib in NRAS-Mutant Advanced Melanoma | Melanoma Advanced | Recruiting |
| NCT07358520 | Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to… | Proteinuria | Not Yet Recruiting |
| Phase 3 | |||
| NCT06676449 | TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC | Esophageal Carcinoma | Recruiting |
| NCT05909332 | Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant… | Breast Cancer | Recruiting |
| NCT07019363 | CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk… | Breast Cancer | Recruiting |
| NCT07362914 | Corticosteroids for Doxorubicin Liposome-Induced Hand-Foot-Skin Reactions | Breast Cancer | Recruiting |
| NCT06554652 | Selective Neck Dissection Versus Modified Neck Dissection in PTC | Thyroid Cancer | Recruiting |
| NCT06558981 | Adjuvant Radiotherapy in High Risk Locally Advanced DTC | Thyroid Cancer | Recruiting |
| NCT05806060 | Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally… | Triple-Negative Breast Cancer | Recruiting |
| NCT07300514 | Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma | Maintenance Treatment of Peripheral T-cell Lymphoma | Recruiting |
| NCT06964568 | CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC | Esophageal Carcinoma | Recruiting |
| NCT06402708 | Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3) | Thymic Carcinoma | Recruiting |
| NCT07615751 | Pyrotinib and Trastuzumab Combined With Dalpiciclib Versus Combined With Docetaxel in… | Breast Cancer | Recruiting |
| NCT07362836 | Fruquintinib Versus Bevacizumab Plus Chemotherapy in Second-Line RAS-Mutant Metastatic… | Colorectal Cancer | Not Yet Recruiting |
| NCT03399110 | XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC) | Gastric Cancer | Active, Not Recruiting |
| NCT07382687 | Famitinib Combined With SHR-A1811, Versus SHR-A1811 for CDK4/6 Inhibitors-resistent… | Breast Cancer | Not Yet Recruiting |
| NCT07407517 | Adjuvant Intensification for LAR | Breast Cancer Females | Not Yet Recruiting |
| NCT07432178 | CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk… | Breast Cancer | Not Yet Recruiting |
| NCT07528716 | Artificial Intelligence Model-Guided Neoadjuvant Anti-HER2 Targeted Therapy | Breast Cancer | Not Yet Recruiting |
| NCT07551479 | SCRT Based iTNT vs. LCRT Based TNT for MSS Locally Advanced Rectal Cancer | Locally Advanced Rectal Cancer (LARC) | Not Yet Recruiting |
| NCT07554846 | Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant… | Resectable Stage II-IIIa NSCLC | Not Yet Recruiting |
| NCT07628504 | Sac-TMT Sequential Capecitabine Versus Capecitabine in Early-Stage High-Risk… | Adjuvant Drug Therapy | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT07319429 | Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular… | Endometrial Cancer | Recruiting |
| NCT07366840 | RC48 Combined With Chemotherapy in HER2-Positive Advanced Breast Cancer Patients With… | HER2-positive Breast Cancer | Not Yet Recruiting |
| Phase 2 | |||
| NCT06547736 | Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer | Pancreatic Cancer | Recruiting |